antiviral agents

Preferred Label : antiviral agents;

MeSH definition : Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.;

MeSH synonym : drugs, antiviral; agents, antiviral; antiviral drugs; antivirals; Antiviral; Antiviral Drug; Drug, Antiviral; Antiviral Agent; Agent, Antiviral;

MeSH annotation : for resistance to antiviral agents, DRUG RESISTANCE, VIRAL and DRUG RESISTANCE, MULTIPLE, VIRAL are available;

Wikipedia link : https://en.wikipedia.org/wiki/Antiviral drug;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000998;

UMLS CUI

C0003451;

ATC code(s)
- antivirals [ATC Code]
- antivirals [ATC Code]
ATC code(s)
- Antiviral monoclonal antibodies [ATC Code]
- Antivirals for treatment of HCV infections [ATC Code]
- adefovir dipivoxil [ATC Code]
- antivirals [ATC Code]
- antivirals [ATC Code]
- antivirals for systemic use [ATC Code]
- antivirals for treatment of hiv infections, combinations [ATC Code]
- brivudine [ATC Code]
- cidofovir [ATC Code]
- clevudine [ATC Code]
- direct acting antivirals [ATC Code]
- entecavir [ATC Code]
- famciclovir [ATC Code]
- foscarnet [ATC Code]
- fosfonet [ATC Code]
- ganciclovir [ATC Code]
- idoxuridine [ATC Code]
- inosine pranobex [ATC Code]
- metisazone [ATC Code]
- moroxydine [ATC Code]
- oseltamivir [ATC Code]
- other antivirals [ATC Code]
- penciclovir [ATC Code]
- pleconaril [ATC Code]
- rimantadine [ATC Code]
- sinecatechins [ATC Code]
- telbivudine [ATC Code]
- tromantadine [ATC Code]
- valaciclovir [ATC Code]
- valganciclovir [ATC Code]
- vidarabine [ATC Code]
- zanamivir [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Anti-infective antiviral [ICD-11 Extension code]
- Substance with antiviral mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Antiviral Agent [NCIt concept]
- Antiviral drugs [Bloc CIM-11]
- Product containing antiviral (product) [SNOMED CT concept]
- antiviral agent, nos [SNOMED Notion]
- antivirals [ATC Code]
- antivirals [ATC Code]
False automatic mappings
- Antiviral drugs [ICD-10 Sub-category (who)]
- Poisoning by, adverse effect of and underdosing of antiviral drugs [ICD-10 Sub-category]
Indexing information
- (1S,7R,8aS)-1,8a-dihydroxy-7-methyl-6,8-dioxo-3-(E-prop-1-enyl)- 6,7,8,8a-tetrahydro-1H-isochromen-7-yl 2,4-dihydroxy-6-methylbenzoate [MeSH Supplementary Concept]
- 12-N-(m-cyanobenzenesulfonyl)-delta(betagamma)-sophocarpinic acid [MeSH Supplementary Concept]
- 13-hexylberberine [MeSH Supplementary Concept]
- 2'-(glutathion-S-yl)-deschlorodiclofenac [MeSH Supplementary Concept]
- 2'-deoxy-3'-(4,4'-dimethoxy-2'-methoxycarbonyl-5,6,5',6'-bis(methylenedioxy)-1,1'-biphenyl-2-carboxyl)uridine [MeSH Supplementary Concept]
- 2,3-difluorosialic acid [MeSH Supplementary Concept]
- 2-((1-hydroxy-4-(4-methyl-3-nitrobenzenesulfonamido)naphthalen-2-yl)sulfanyl)acetic acid [MeSH Supplementary Concept]
- 2-(3-((3,5-dichlorophenyl)thio)-6-methyl-1H-indol-2-yl)acetamide [MeSH Supplementary Concept]
- 2-amino-9-(2,3-dideoxy-2,3-dihydro-beta-D-arabinofuranosyl)-6-methoxy-9H-purine [MeSH Supplementary Concept]
- 2-hydroxystilbamidine isethionate [MeSH Supplementary Concept]
- 2-methyl-3-phenyl-2H-(1,2,4)thiadiazol-5-ylideneamine [MeSH Supplementary Concept]
- 22,23-dihydroxystigmast-4-en-3-one [MeSH Supplementary Concept]
- 23-(s)-2-amino-3-phenylpropanoylsilybin [MeSH Supplementary Concept]
- 3',5'-di-O-trityluridine [MeSH Supplementary Concept]
- 3-(3-((3,5-dichlorophenyl)thio)-6-methyl-1H-indol-2-yl)propanamide [MeSH Supplementary Concept]
- 3-O-(6'-O-butyl-beta-D-glucuronopyranosyl)-oleanolic acid-28-O-beta-D-glucopyranosyl ester [MeSH Supplementary Concept]
- 3-O-beta-D-glucopyranosyl (1-3)-O-(beta-D-glucopyranosyl-oleanolic acid)-28-O-beta-D-glucuronopyranoside [MeSH Supplementary Concept]
- 3-isopinocampheylamine [MeSH Supplementary Concept]
- 4'-azido-2'-deoxy-2'-fluoro-3'-(4,4'-dimethoxy-2'-methoxycarbonyl-5,6,5',6'-bis(methylenedioxy)-1,1'-biphenyl-2-carboxyl)cytidine [MeSH Supplementary Concept]
- 4-(2,2-difluoroacetylamino)-5-amino-3-(1-ethylpropoxy)cyclohex-1-enecarboxylic acid [MeSH Supplementary Concept]
- 4-chloro-N'-thieno(2,3-d)pyrimidin-4-ylbenzenesulfonohydrazide [MeSH Supplementary Concept]
- 5,6-dimethyl-3H,3'H-spiro(benzofuran-2,1'-isobenzofuran)-3,3'-dione [MeSH Supplementary Concept]
- 6-(3-cyano-6-ethyl-5-fluoro-1-(pyrimidin-2-yl)-1H-indol-2-yl)-N-(1,1,1-trifluoropropan-2-yl)pyridine-3-sulfonamide [MeSH Supplementary Concept]
- 6-bromoindirubin-3'-acetoxime [MeSH Supplementary Concept]
- 6-phosphonylmethoxyethoxy-2,4-diaminopyrimidine [MeSH Supplementary Concept]
- 7-hydroxyisoflavone [MeSH Supplementary Concept]
- 8-cyclohexyl-N-((dimethylamino)sulfonyl)-1,1a,2,12b-tetrahydro-11-methoxy-1a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)cycloprop(d)indolo(2,1-a)(2)benzazepine-5-carboxamide [MeSH Supplementary Concept]
- 9-dehydro-17-hydro-andrographolide-19-yl sulfuric acid [MeSH Supplementary Concept]
- AL18 compound [MeSH Supplementary Concept]
- APS-1 polysaccharide sulfate [MeSH Supplementary Concept]
- Apobec3 protein, mouse [MeSH Supplementary Concept]
- BI 201302 [MeSH Supplementary Concept]
- BMS-605339 [MeSH Supplementary Concept]
- BP008 [MeSH Supplementary Concept]
- CM-10-18 compound [MeSH Supplementary Concept]
- EPs 7630 [MeSH Supplementary Concept]
- GS-9451 [MeSH Supplementary Concept]
- IFNL1 protein, human [MeSH Supplementary Concept]
- IFNL2 protein, human [MeSH Supplementary Concept]
- IFNL3 protein, human [MeSH Supplementary Concept]
- IFNL4 protein, human [MeSH Supplementary Concept]
- LADANIA067 [MeSH Supplementary Concept]
- Leflunomide [MeSH Descriptor]
- PF-04849285 [MeSH Supplementary Concept]
- RC 183 protein, rozites caperata [MeSH Supplementary Concept]
- SG220 compound [MeSH Supplementary Concept]
- SG273 compound [MeSH Supplementary Concept]
- ST-193 [MeSH Supplementary Concept]
- WC5 compound [MeSH Supplementary Concept]
- apilarnil [MeSH Supplementary Concept]
- ching-fang-pai-tu-san [MeSH Supplementary Concept]
- dehydrocheilanthifoline [MeSH Supplementary Concept]
- dufulin [MeSH Supplementary Concept]
- echinaforce [MeSH Supplementary Concept]
- ethyl 4-(2-bromo-4-fluorophenyl)-6-(morpholinomethyl)-2-(2-thiazolyl)-1,4-dihydropyrimidine-5-carboxylate [MeSH Supplementary Concept]
- ethyl 5-(hydroxymethyl)-1-methyl-2-(phenysulfanylmethyl)-1H-indole-3-carboxylate [MeSH Supplementary Concept]
- fluoro-homoneplanocin A [MeSH Supplementary Concept]
- glaucogenin D [MeSH Supplementary Concept]
- glycan sialylneolacto-N-tetraose c [MeSH Supplementary Concept]
- hederagenin-3-O-beta-D-glucuronopyranoside [MeSH Supplementary Concept]
- interferon-lambda, human [MeSH Supplementary Concept]
- isoaspulvinone E [MeSH Supplementary Concept]
- larifan [MeSH Supplementary Concept]
- ledipasvir [MeSH Supplementary Concept]
- liu-he-tang [MeSH Supplementary Concept]
- methyl 3, 4-dihydroxyphenylacetate [MeSH Supplementary Concept]
- myriberine A [MeSH Supplementary Concept]
- ombitasvir [MeSH Supplementary Concept]
- paritaprevir [MeSH Supplementary Concept]
- pritelivir [MeSH Supplementary Concept]
- spirooliganone A [MeSH Supplementary Concept]
- stellarmedin A protein, Stellaria media [MeSH Supplementary Concept]
- sweriyunnangenin A [MeSH Supplementary Concept]
- tenofovir alafenamide [MeSH Supplementary Concept]
- tenofovir diphosphate [MeSH Supplementary Concept]
- theaflavin-3,3'-digallate [MeSH Supplementary Concept]
- vesatolimod [MeSH Supplementary Concept]
Mapping VCM exact
- infection viral [VCM modifier]
Metaterm(s)
- virology [CISMeF Metaterm]
Record concept(s)
- antiviral agents [MeSH concept]
See also
- interferon inducers [MeSH Descriptor]
- reverse transcriptase inhibitors [MeSH Descriptor]
- virus diseases [MeSH Descriptor]
- virus inactivation [MeSH Descriptor]
- viruses [MeSH Descriptor]
See also inter- (CISMeF)
- Medicinal product acting as antiviral agent (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-(beta-D-arabinofuranosyl)-5-ethyluracil [MeSH Supplementary Concept]
- 1-Deoxynojirimycin [MeSH Descriptor]
- 1-adamantyl (5-bromo-2-methoxybenzyl) amine [MeSH Supplementary Concept]
- 1-beta-arabinofuranosyl-5-(2-chlorovinyl)uracil [MeSH Supplementary Concept]
- 2',3'-dideoxyguanosine [MeSH Supplementary Concept]
- 2',5'-oligoadenylate [MeSH Supplementary Concept]
- 2'-O-glycyl acyclovir [MeSH Supplementary Concept]
- 2'-deoxy-2'-fluoroguanosine [MeSH Supplementary Concept]
- 2'-deoxy-2'-methylenecytidine [MeSH Supplementary Concept]
- 2'-deoxyadenosine [MeSH Supplementary Concept]
- 2'-fluoro-5-ethylarabinosyluracil [MeSH Supplementary Concept]
- 2-amino-1,9-dihydro-9-(3-hydroxy-4-(hydroxymethyl)cyclopentyl)-6H-purine-6-one [MeSH Supplementary Concept]
- 2-fluoro-araATP [MeSH Supplementary Concept]
- 2-thiothymidine [MeSH Supplementary Concept]
- 3'-amino-2',3'-dideoxyuridine [MeSH Supplementary Concept]
- 3-(1H-indol-3-yl)-2,3-dihydro-4H-furo(3,2-c)chromen-4-one [MeSH Supplementary Concept]
- 3-cyano-4,6-diphenylpyridine [MeSH Supplementary Concept]
- 4'-cyano-2'-deoxyguanosine [MeSH Supplementary Concept]
- 5'-guanylylmethylenebisphosphonate [MeSH Supplementary Concept]
- 5'-thioadenosine [MeSH Supplementary Concept]
- 5-((methylthio)methyl)-2'-deoxyuridine [MeSH Supplementary Concept]
- 5-(2-bromoethyl)-2'-deoxyuridine [MeSH Supplementary Concept]
- 5-(2-bromovinyl)-2'-deoxycytidine [MeSH Supplementary Concept]
- 5-(2-bromovinyl)uridine [MeSH Supplementary Concept]
- 5-(2-chloroethyl)-2'-deoxyuridine [MeSH Supplementary Concept]
- 5-(2-chlorovinyl)-2'-deoxyuridine [MeSH Supplementary Concept]
- 5-(2-fluorovinyl)-2'-deoxyuridine [MeSH Supplementary Concept]
- 5-(2-iodovinyl)-2'-deoxyuridine [MeSH Supplementary Concept]
- 5-(3,3,3-trifluoro-1-propenyl) 2'-deoxyuridine [MeSH Supplementary Concept]
- 5-(aminomethyl)-2'-deoxyuridine [MeSH Supplementary Concept]
- 5-bromouridine [MeSH Supplementary Concept]
- 5-mercapto-2'-deoxyuridine [MeSH Supplementary Concept]
- 5-propynylarabinofuranosyluracil [MeSH Supplementary Concept]
- 5-vinyl-1-arabinofuranosyluracil [MeSH Supplementary Concept]
- 6-chloropurine [MeSH Supplementary Concept]
- 6-methoxypurine arabinoside [MeSH Supplementary Concept]
- 8-ethyladenosine [MeSH Supplementary Concept]
- 8-hydroxyacyclovir [MeSH Supplementary Concept]
- 8-methoxy-2'-deoxyguanosine [MeSH Supplementary Concept]
- 9-((2,3-dihydroxy-1-propoxy)methyl)guanine [MeSH Supplementary Concept]
- 9-((2-hydroxy-1,3,2-dioxaphosphorinan-5-yl)oxymethyl)guanine P-oxide [MeSH Supplementary Concept]
- 9-(1,3-dihydroxy-2-propoxymethyl)-GMP [MeSH Supplementary Concept]
- 9-(2,3-dihydroxypropyl)adenine [MeSH Supplementary Concept]
- 9-(2-hydroxy-3-nonyl)adenine [MeSH Supplementary Concept]
- 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine [MeSH Supplementary Concept]
- 9-(4-hydroxy-3-hydroxymethyl-2-butenyl)guanine [MeSH Supplementary Concept]
- 9-(5'-deoxy-5'-(methylthio)-xylofuranosyl)adenine [MeSH Supplementary Concept]
- 9-(S)-(3-hydroxy-2-(phosphonomethoxy)propyl)adenine [MeSH Supplementary Concept]
- 9-beta-D-arabinofuranosylguanosine 5'-triphosphate [MeSH Supplementary Concept]
- 9-carboxymethoxymethylguanine [MeSH Supplementary Concept]
- 9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 [MeSH Supplementary Concept]
- Artesunate [MeSH Descriptor]
- BIOLF 143 [MeSH Supplementary Concept]
- BMS-986097 [MeSH Supplementary Concept]
- Cidofovir [MeSH Descriptor]
- Famciclovir [MeSH Descriptor]
- GLA 60 [MeSH Supplementary Concept]
- GS-441524 [MeSH Supplementary Concept]
- GS-441524 triphosphate [MeSH Supplementary Concept]
- Interferon alpha-2 [MeSH Descriptor]
- Interferon beta-1a [MeSH Descriptor]
- JNJ-56136379 [MeSH Supplementary Concept]
- JNJ-632 [MeSH Supplementary Concept]
- MEDI8852 [MeSH Supplementary Concept]
- N-(guanosin-8-yl)-4-aminobiphenyl [MeSH Supplementary Concept]
- N-chlorotaurine [MeSH Supplementary Concept]
- N-methyldeoxynojirimycin [MeSH Supplementary Concept]
- PC-786 [MeSH Supplementary Concept]
- Palivizumab [MeSH Descriptor]
- REP 2139 [MeSH Supplementary Concept]
- Roscovitine [MeSH Descriptor]
- Simeprevir [MeSH Descriptor]
- Sofosbuvir [MeSH Descriptor]
- Telbivudine [MeSH Descriptor]
- Valacyclovir [MeSH Descriptor]
- Valganciclovir [MeSH Descriptor]
- acemannan [MeSH Supplementary Concept]
- acetylcysteine [MeSH Descriptor]
- acyclovir [MeSH Descriptor]
- acyclovir monophosphate [MeSH Supplementary Concept]
- acyclovir triphosphate [MeSH Supplementary Concept]
- adafosbuvir [MeSH Supplementary Concept]
- adenylyl-(3'-5')-virazole [MeSH Supplementary Concept]
- ajoene [MeSH Supplementary Concept]
- alovudine [MeSH Supplementary Concept]
- alpha-terthienyl [MeSH Supplementary Concept]
- amantadine [MeSH Descriptor]
- amiprilose [MeSH Supplementary Concept]
- ammonium tungsten antimonate hydroxide oxide [MeSH Supplementary Concept]
- amonafide [MeSH Supplementary Concept]
- andrographolide [MeSH Supplementary Concept]
- ansuvimab [MeSH Supplementary Concept]
- aphidicolin [MeSH Descriptor]
- arabinofuranosyl-E-5-iodovinyluracil [MeSH Supplementary Concept]
- arildone [MeSH Supplementary Concept]
- aristolochic acid I [MeSH Supplementary Concept]
- astegolimab [MeSH Supplementary Concept]
- atoltivimab [MeSH Supplementary Concept]
- atoltivimab, maftivimab, and odesivimab-ebgn drug combination [MeSH Supplementary Concept]
- avarol [MeSH Supplementary Concept]
- avdoralimab [MeSH Supplementary Concept]
- avridine [MeSH Supplementary Concept]
- baloxavir [MeSH Supplementary Concept]
- bamlanivimab [MeSH Supplementary Concept]
- beta-aspartylhydroxamic acid [MeSH Supplementary Concept]
- bifidobacterin [MeSH Supplementary Concept]
- brefeldin A [MeSH Descriptor]
- brincidofovir [MeSH Supplementary Concept]
- brivudine [MeSH Supplementary Concept]
- bromodeoxyuridine [MeSH Descriptor]
- buciclovir [MeSH Supplementary Concept]
- carbopol 940 [MeSH Supplementary Concept]
- casirivimab and imdevimab drug combination [MeSH Supplementary Concept]
- cilgavimab and tixagevimab drug combination [MeSH Supplementary Concept]
- clevudine [MeSH Supplementary Concept]
- concanamycin A [MeSH Supplementary Concept]
- costunolide [MeSH Supplementary Concept]
- curdlan sulfate [MeSH Supplementary Concept]
- cytarabine [MeSH Descriptor]
- cytosinpeptidemycin [MeSH Supplementary Concept]
- deoxyglucose [MeSH Descriptor]
- deoxypodophyllotoxin [MeSH Supplementary Concept]
- desciclovir [MeSH Supplementary Concept]
- didemnins [MeSH Supplementary Concept]
- dideoxyadenosine [MeSH Descriptor]
- disoxaril [MeSH Supplementary Concept]
- ditiocarb [MeSH Descriptor]
- docosanol [MeSH Supplementary Concept]
- edoxudin [MeSH Supplementary Concept]
- elbasvir-grazoprevir drug combination [MeSH Supplementary Concept]
- enocitabine [MeSH Supplementary Concept]
- entecavir [MeSH Supplementary Concept]
- favipiravir [MeSH Supplementary Concept]
- fiacitabine [MeSH Supplementary Concept]
- fialuridine [MeSH Supplementary Concept]
- filipin [MeSH Descriptor]
- fomivirsen [MeSH Supplementary Concept]
- galidesivir [MeSH Supplementary Concept]
- ganciclovir [MeSH Descriptor]
- ganciclovir triphosphate [MeSH Supplementary Concept]
- geldanamycin [MeSH Supplementary Concept]
- gimsilumab [MeSH Supplementary Concept]
- gontivimab [MeSH Supplementary Concept]
- grazoprevir [MeSH Supplementary Concept]
- heptanoyl-gamma-D-glutamyl-L-meso-diaminopimelyl-D-alanine [MeSH Supplementary Concept]
- houttuynoid A [MeSH Supplementary Concept]
- hydroxyguanidine [MeSH Supplementary Concept]
- hypericin [MeSH Supplementary Concept]
- hypocrellin A [MeSH Supplementary Concept]
- hypoxanthine arabinoside [MeSH Supplementary Concept]
- ibacitabine [MeSH Supplementary Concept]
- idoxuridine [MeSH Descriptor]
- inosine pranobex [MeSH Descriptor]
- interferon alfacon-1 [MeSH Supplementary Concept]
- interferon tau [MeSH Supplementary Concept]
- interferon type i [MeSH Descriptor]
- interferon-alfa-1b [MeSH Supplementary Concept]
- interferon-alpha [MeSH Descriptor]
- interferon-beta [MeSH Descriptor]
- interferon-gamma [MeSH Descriptor]
- interferons [MeSH Descriptor]
- iodoantipyrine [MeSH Supplementary Concept]
- jacalin [MeSH Supplementary Concept]
- kethoxal [MeSH Supplementary Concept]
- laninamivir [MeSH Supplementary Concept]
- lapachol [MeSH Supplementary Concept]
- ledipasvir [MeSH Supplementary Concept]
- ledipasvir, sofosbuvir drug combination [MeSH Supplementary Concept]
- letermovir [MeSH Supplementary Concept]
- lexitropsin [MeSH Supplementary Concept]
- maftivimab [MeSH Supplementary Concept]
- maribavir [MeSH Supplementary Concept]
- meplazumab [MeSH Supplementary Concept]
- merocyanine dye [MeSH Supplementary Concept]
- methisazone [MeSH Descriptor]
- mitonafide [MeSH Supplementary Concept]
- molnupiravir [MeSH Supplementary Concept]
- moroxydine [MeSH Supplementary Concept]
- neplanocin A [MeSH Supplementary Concept]
- netropsin [MeSH Descriptor]
- nirmatrelvir and ritonavir drug combination [MeSH Supplementary Concept]
- odalasvir [MeSH Supplementary Concept]
- odesivimab [MeSH Supplementary Concept]
- oseltamivir [MeSH Descriptor]
- oxetanocin [MeSH Supplementary Concept]
- oxymatrine [MeSH Supplementary Concept]
- palmidrol [MeSH Supplementary Concept]
- peginterferon alfa-2a [MeSH Supplementary Concept]
- peginterferon alfa-2b [MeSH Supplementary Concept]
- penciclovir [MeSH Supplementary Concept]
- pentanedioic acid imidazolyl ethanamide [MeSH Supplementary Concept]
- pepsinated immunoglobulin G [MeSH Supplementary Concept]
- peramivir [MeSH Supplementary Concept]
- picrosteganol [MeSH Supplementary Concept]
- pleconaril [MeSH Supplementary Concept]
- plonmarlimab [MeSH Supplementary Concept]
- pocapavir [MeSH Supplementary Concept]
- poly A-U [MeSH Descriptor]
- poly I-C [MeSH Descriptor]
- poly(I).poly(c12,U) [MeSH Supplementary Concept]
- polysaccharide-K [MeSH Supplementary Concept]
- pritelivir [MeSH Supplementary Concept]
- prostaglandin A1 [MeSH Supplementary Concept]
- pseudohypericin [MeSH Supplementary Concept]
- pyran copolymer [MeSH Descriptor]
- pyrazofurin [MeSH Supplementary Concept]
- racivir [MeSH Supplementary Concept]
- radavirsen [MeSH Supplementary Concept]
- remdesivir [MeSH Supplementary Concept]
- remestemcel-l [MeSH Supplementary Concept]
- ribavirin [MeSH Descriptor]
- ribavirin 5'-triphosphate [MeSH Supplementary Concept]
- ribavirin-5'-phosphate [MeSH Supplementary Concept]
- ridostin [MeSH Supplementary Concept]
- rimantadine [MeSH Descriptor]
- rupintrivir [MeSH Supplementary Concept]
- ruzasvir [MeSH Supplementary Concept]
- saikosaponin D [MeSH Supplementary Concept]
- san wu huangqin [MeSH Supplementary Concept]
- scequinadoline A [MeSH Supplementary Concept]
- seco-A-oleanane-3,4-lactone [MeSH Supplementary Concept]
- selenazofurin [MeSH Supplementary Concept]
- selenocystine [MeSH Supplementary Concept]
- silicon phthalocyanine [MeSH Supplementary Concept]
- sofosbuvir-velpatasvir drug combination [MeSH Supplementary Concept]
- sorivudine [MeSH Supplementary Concept]
- sparfosic acid [MeSH Supplementary Concept]
- stallimycin [MeSH Supplementary Concept]
- stepronin [MeSH Supplementary Concept]
- streptovaricin [MeSH Descriptor]
- surfactin peptide [MeSH Supplementary Concept]
- taribavirin [MeSH Supplementary Concept]
- tenuazonic acid [MeSH Descriptor]
- tetrandrine [MeSH Supplementary Concept]
- thymidine 5'-O-(1-thiotriphosphate) [MeSH Supplementary Concept]
- thymidine 5'-diphosphate [MeSH Supplementary Concept]
- thymine arabinoside [MeSH Supplementary Concept]
- tilorone [MeSH Descriptor]
- tricyclodecane-9-yl-xanthogenate [MeSH Supplementary Concept]
- trifluridine [MeSH Descriptor]
- troclosene [MeSH Supplementary Concept]
- tromantadine [MeSH Supplementary Concept]
- tunicamycin [MeSH Descriptor]
- uprifosbuvir [MeSH Supplementary Concept]
- ursodoxicoltaurine [MeSH Supplementary Concept]
- velpatasvir [MeSH Supplementary Concept]
- vesatolimod [MeSH Supplementary Concept]
- vesnarinone [MeSH Supplementary Concept]
- vidarabine [MeSH Descriptor]
- vidarabine phosphate [MeSH Descriptor]
- viroxime [MeSH Supplementary Concept]
- yimitasvir [MeSH Supplementary Concept]
- zanamivir [MeSH Descriptor]
- zansecimab [MeSH Supplementary Concept]
- ziresovir [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Anti-infective antiviral [ICD-11 Extension code]
- Antiviral Agent [NCIt concept]
- Antiviral drugs [Bloc CIM-11]
- Antivirals [LOINC hierarchical part]
- Medicinal product acting as antiviral agent (product) [SNOMED CT concept]
- Product containing antiviral (product) [SNOMED CT concept]
- Substance with antiviral mechanism of action (substance) [SNOMED CT concept]
- antiviral agent, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients